UCB Launches Legion Of Suits To Protect Epilepsy Drug IP
German pharmaceuticals giant UCB Pharma GmbH hit more than a dozen generic-drug manufacturers with suits in Delaware federal court Wednesday, accusing Sandoz Inc., Amneal Pharmaceuticals LLC, Apotex Corp. and others of...To view the full article, register now.
Already a subscriber? Click here to view full article